Wellington Management Group
NKTR icon

Wellington Management Group’s Nektar Therapeutics NKTR Stock Holding History

Wellington Management Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,827
Closed -$486K – 2015
2024
Q4 		$486K Buy
34,827
+3,288
+10% +$58K ﹤0.01% 1837
2024
Q3 		$615K Buy
+31,539
New +$601K ﹤0.01% 1792
2022
Q4 		– Sell
-758,915
Closed -$36.4M – 2073
2022
Q3 		$36.4M Hold
758,915
– – 0.01% 743
2022
Q2 		$43.3M Hold
758,915
– – 0.01% 721
2022
Q1 		$61.4M Hold
758,915
– – 0.01% 694
2021
Q4 		$154M Hold
758,915
– – 0.02% 514
2021
Q3 		$204M Hold
758,915
– – 0.03% 432
2021
Q2 		$195M Hold
758,915
– – 0.03% 446
2021
Q1 		$228M Sell
758,915
-133,926
-15% -$41.7M 0.04% 398
2020
Q4 		$228M Sell
892,841
-117,349
-12% -$30.3M 0.04% 381
2020
Q3 		$251M Buy
1,010,190
+91
+0% +$28.6K 0.05% 312
2020
Q2 		$351M Sell
1,010,099
-39,698
-4% -$12.4M 0.08% 222
2020
Q1 		$281M Sell
1,049,797
-28,508
-3% -$8.82M 0.07% 235
2019
Q4 		$349M Sell
1,078,305
-21,758
-2% -$6.31M 0.07% 270
2019
Q3 		$301M Buy
1,100,063
+234,710
+27% +$86.1M 0.07% 277
2019
Q2 		$462M Buy
865,353
+1,249
+0.1% +$626K 0.1% 216
2019
Q1 		$436M Buy
864,104
+148,013
+21% +$87.7M 0.1% 216
2018
Q4 		$353M Buy
716,091
+202,550
+39% +$122M 0.09% 238
2018
Q3 		$470M Buy
513,541
+58,925
+13% +$50.3M 0.1% 221
2018
Q2 		$333M Buy
454,616
+222,972
+96% +$257M 0.07% 273
2018
Q1 		$369M Buy
231,644
+96,833
+72% +$125M 0.08% 249
2017
Q4 		$121M Buy
+134,811
New +$79.7M 0.03% 502
2015
Q1 		– Sell
-10,111
Closed -$2.35M – 2212
2014
Q4 		$2.35M Sell
10,111
-151
-1% -$32.3K ﹤0.01% 1651
2014
Q3 		$1.86M Buy
10,262
+2,680
+35% +$513K ﹤0.01% 1694
2014
Q2 		$1.46M Buy
7,582
+369
+5% +$65.3K ﹤0.01% 1742
2014
Q1 		$1.31M Buy
+7,213
New +$1.43M ﹤0.01% 1773

Other funds holding NKTR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Wellington Management Group's NKTR Position: Q1 2025 in Review

Wellington Management Group sold out of Nektar Therapeutics (NKTR) in Q1 2025, closing a stake of 34,827 shares — an estimated $486K sold.

Wellington Management Group first reported a position in NKTR in Q1 2014 and held it in 26 quarters. The position peaked at $470M in Q3 2018. 154 funds tracked by Wall St. Rank hold NKTR as of Q1 2025.

  • Wellington Management Group reported no remaining Nektar Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Wellington Management Group sold 34,827 Nektar Therapeutics shares in Q1 2025, an estimated $486K.
  • Wellington Management Group first reported a position in Nektar Therapeutics in Q1 2014 and held it in 26 quarters.
  • Wellington Management Group's Nektar Therapeutics position peaked at $470M in Q3 2018.
  • 154 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2025.

Based on Wellington Management Group's 13F filing for Q1 2025, filed 13 May 2025.